z-logo
open-access-imgOpen Access
Effects of rifampin on biliary lipids in humans
Author(s) -
Klaus Bergmann,
Joshua Fierer,
Henry Mok,
Scott M. Grundy
Publication year - 1981
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.19.2.342
Subject(s) - chenodeoxycholic acid , cholic acid , bile acid , gallbladder , cholesterol , medicine , deoxycholic acid , gastroenterology , biology , chemistry , biochemistry
Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions f individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here